Lineage-specific silencing of human IL-10 gene expression by promoter methylation in cervical cancer cells
- PMID: 18378443
- DOI: 10.1016/j.ejca.2008.02.046
Lineage-specific silencing of human IL-10 gene expression by promoter methylation in cervical cancer cells
Abstract
Epigenetic analysis was performed to demonstrate that the normal and neoplastic epithelial cells do not serve as the source of the locally elevated IL-10 production during cervical carcinogenesis. Bisulfite sequencing was used to correlate promoter CpG methylation with the transcription of the gene. Lack of IL-10 transcription in HeLa, SiHa, Caski, HT-3, C33-A, HaCaT cell lines and in primary human keratinocytes correlated consistently with the methylated state of the proximal CpG residues, particularly with the two most proximal CpGs at positions -185 and -110. These two sites were also highly methylated in normal and malignant cervical cells directly isolated from patient material. On the other hand, IL-10 producing peripheral blood mononuclear cells had unmethylated CpG residues in the proximal promoter associated with acetylated H3 and H4 histones as determined by chromatin immunoprecipitation. In HeLa carrying epigenetically silenced endogeneous IL-10 promoter, the transfected non-CpG methylated 1 kb and 0.6 kb proximal promoter fragments could drive reporter gene expression, which was reversed by cassette methylation of these promoter fragments. In conclusion, the CpG methylation pattern of the proximal promoter is implicated as a major determinant of transcriptional silencing of human IL-10 expression in cells of cervical epithelial origin.
Similar articles
-
IGSF4 promoter methylation and expression silencing in human cervical cancer.Gynecol Oncol. 2005 Jan;96(1):150-8. doi: 10.1016/j.ygyno.2004.08.050. Gynecol Oncol. 2005. PMID: 15589594
-
Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.J Pathol. 2009 Nov;219(3):327-36. doi: 10.1002/path.2598. J Pathol. 2009. PMID: 19662663
-
Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.Cancer Chemother Pharmacol. 2009 Mar;63(4):605-13. doi: 10.1007/s00280-008-0773-z. Epub 2008 Jun 3. Cancer Chemother Pharmacol. 2009. PMID: 18521605
-
Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.Cancer Lett. 2007 Mar 18;247(2):318-27. doi: 10.1016/j.canlet.2006.05.013. Epub 2006 Jun 27. Cancer Lett. 2007. PMID: 16806674
-
Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines.Gynecol Oncol. 2008 May;109(2):270-4. doi: 10.1016/j.ygyno.2008.01.034. Epub 2008 Apr 2. Gynecol Oncol. 2008. PMID: 18377964
Cited by
-
Highlights in pathogenesis of vitiligo.World J Clin Cases. 2015 Mar 16;3(3):221-30. doi: 10.12998/wjcc.v3.i3.221. World J Clin Cases. 2015. PMID: 25789295 Free PMC article. Review.
-
Prostaglandin E2 Reverses the Effects of DNA Methyltransferase Inhibitor and TGFB1 on the Conversion of Naive T Cells to iTregs.Transfus Med Hemother. 2020 Jun;47(3):244-253. doi: 10.1159/000502582. Epub 2019 Sep 19. Transfus Med Hemother. 2020. PMID: 32595429 Free PMC article.
-
5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity.Mediators Inflamm. 2014;2014:418292. doi: 10.1155/2014/418292. Epub 2014 Mar 13. Mediators Inflamm. 2014. PMID: 24757283 Free PMC article.
-
Cell type-specific regulation of IL-10 expression in inflammation and disease.Immunol Res. 2010 Jul;47(1-3):185-206. doi: 10.1007/s12026-009-8150-5. Immunol Res. 2010. PMID: 20087682 Free PMC article. Review.
-
IL10 hypomethylation is associated with the risk of gastric cancer.Oncol Lett. 2021 Apr;21(4):241. doi: 10.3892/ol.2021.12502. Epub 2021 Jan 31. Oncol Lett. 2021. PMID: 33664805 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical